Diagnosis requires careful consideration of mimicking conditions and a broader list of differential diagnoses in those infants with poor growth or frequent infections, Dr. Elaine Siegfried said.
The JAK inhibitor was generally well tolerated among the adolescents, with mild or moderate acne being the most common adverse event, the authors reported.